To our knowledge, these findings provide the novel PLPP/CIN-mediated mechanism underlying seizure progression by modulating NEDD4-2-mediated GluA1 ubiquitination and suggest the development of therapeutic strategies for various neurological and psychiatric disorders, including epilepsy. Here, NEDD4L is linked to epilepsy.